دورية أكاديمية

Isavuconazole Treatment of Spinal Cord Invasive Aspergillosis Guided by Cerebrospinal Fluid (1,3)-β-d-Glucan Levels in a Patient with Low Interferon-Gamma and Ulcerative Colitis.

التفاصيل البيبلوغرافية
العنوان: Isavuconazole Treatment of Spinal Cord Invasive Aspergillosis Guided by Cerebrospinal Fluid (1,3)-β-d-Glucan Levels in a Patient with Low Interferon-Gamma and Ulcerative Colitis.
المؤلفون: O'Regan, Siobhan, O'Kelly, Brendan, Reidy, Paul, O'Toole, Aoibhlinn, Caird, John, McNally, Cora, McConkey, Samuel, de Barra, Eoghan
المصدر: Journal of Fungi; Jun2022, Vol. 8 Issue 6, p557, 7p
مصطلحات موضوعية: ULCERATIVE colitis, SPINAL cord, ASPERGILLOSIS, INTERFERON gamma, CERVICAL cord, PULMONARY aspergillosis, NEUROSURGERY, CEREBROSPINAL fluid
مستخلص: This case highlights the use of (1,3)-beta-d glucan to direct treatment of a cervical spinal cord Aspergillus fumigatus infection in a 22-year-old woman immunocompromised due to steroid and anti-TNF therapy in the context of ulcerative colitis and interferon gamma deficiency. A 4-year treatment course requiring neurosurgical intervention on four occasions and prolonged antifungal therapy, including isavuconazole, resulted in clinical cure with a corresponding decrease in CSF beta-d-glucan to <30 pg/mL. Serum and CSF galactomannan levels were not elevated at any point during the clinical course. [ABSTRACT FROM AUTHOR]
Copyright of Journal of Fungi is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:2309608X
DOI:10.3390/jof8060557